| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.88B | $3.00B | $2.44B |
| YoY Revenue Growth % | +29.5% | +22.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $698.6M | $446.0M | $300.9M |
| Operating Margin % | 18.0% | 14.9% | 12.3% |
| Net Income (GAAP) | $592.0M | $378.0M | $255.0M |
| EBITDA (Normalized) | $838.2M | $553.9M | $388.8M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.26B | $988.2M | $458.0M |
| Capital Expenditures (CapEx) | $174.6M | $134.8M | $109.9M |
| Free Cash Flow (FCF) | $1.08B | $853.3M | $348.0M |
| FCF Margin % | 27.9% | 28.5% | 14.2% |
| Return on Invested Capital (ROIC %) | 28.0% | 19.2% | 6.3% |
| Cash & Short-Term Equivalents | $1.43B | $873.0M | — |
| Total Debt (Short + Long Term) | $1.37B | $1.00B | $1.47B |
| Total Stockholders' Equity | $2.03B | $1.71B | $3.02B |